NASPA Welcomes New President Kelly Fine

NASPA is excited to announce its 2020 President, Kelly Fine. Kelly was sworn in to the President position on March 20, 2020 at the NASPA 2020 Virtual Spring Meeting. Kelly joined the Arizona Pharmacy Association as CEO in October 2011. A graduate of the University of Toledo College of Pharmacy, she came to Arizona in […]

Pharmacist Advocacy Groups Call for New Action to Enhance COVID-19 Patient Care 

Pharmacy organizations representing the interests of all pharmacists in the United States have released a joint set of policy recommendations critical to addressing the COVID-19 pandemic.   The COVID-19 pandemic continues to put an enormous strain on our nation’s healthcare system and the supply of qualified healthcare providers is increasingly limited. With 90% of Americans living within 5 miles of a community pharmacy, pharmacists are positioned to […]

Pharmacy Organizations Request Flexibility on Hand Sanitizer Compounding

NASPA, along with the Alliance for Pharmacy Compounding, the American Pharmacists Association, and the National Community Pharmacists Association, sent a letter to the FDA this morning requesting clarification and flexibility related to compounding hand sanitizers and anticipating additional health emergency needs. “Our organizations welcome the opportunity to meet with FDA for regular productive and proactive […]

USP Compounding Resources for COVID19

From a USP Healthcare Quality & Safety Team email: “In light of the rapidly evolving COVID-19 pandemic, the demand for garbing and personal protective equipment (PPE) and alcohol-based hand sanitizer is expected to outpace available supply. During this pandemic, USP supports State Boards and other regulators using risk-based enforcement discretion related to the implementation of […]

COVID-19 Emergency Declaration

Several days ago, the Trump Administration announced aggressive actions and regulatory flexibilities to help healthcare providers and states respond to and contain the spread of 2019 Novel Coronavirus Disease (COVID-19). The Centers for Medicare & Medicaid Services (CMS) is taking several actions following President Trump’s declaration of a national emergency due to COVID-19 earlier today. […]

Pharmacy Groups Submit Comments to FDA Regarding Prescription Drug Importation

NASPA, in collaboration with other national pharmacy groups, submitted comments opposing the FDA’s proposed rule allowing wholesale importation of prescription drugs from Canada.  The joint comment letter from NASPA and other national pharmacy organizations, including the American Pharmacists Association, National Community Pharmacists Association, American Society of Consultant Pharmacists, Academy of Managed Care Pharmacy, ASHP, and […]